Clinical Trial Detail

NCT ID NCT03005002
Title Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

colorectal cancer

Therapies

Durvalumab + Tremelimumab

Age Groups: adult

No variant requirements are available.